Iris, a growth equity fund targeting European and U.S. purpose-led, consumer-centric brands and tech-enabled solutions, has invested 5.5 million pounds in Biomel, a market-leading, plant-based gut health brand. The investor argued that Biomel created the plant-based gut health market with its series of dairy-free, cultured drinks with rich flavors including Belgian chocolate, vanilla and coconut.
Read More